BHARAT SERUMS AND VACCINES LIMITED

The immunoglobulin market, valued at US$ 13.36 billion in 2023, is projected to reach US$ 28.70 billion by 2034, driven by its use in treating immunodeficiency and other applications. Key growth factors include immunodeficiency disorders, infections, and thrombocytopenia. North America leads with a 46% share, while Asia-Pacific is expected to grow fastest due to increased health spending and prevalence of autoimmune diseases. Recent advancements include subcutaneous injection therapies and acquisitions by major pharmaceutical companies.

CCI approves Mankind Pharma's acquisition of BSV, enhancing biotech and critical care capabilities. CDSCO becomes Affiliate Member of IMDRF, aligning India's medical device regulations with global standards.